Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04182971 · ClinicalTrials.gov registry record · NA
Effect of Added Fruit Pomace Fiber, Juice, and Whole Fruit on Postprandial Glycemia
A NA study, sponsored by PepsiCo Global R&D.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT04182971: Completed NA study, sponsored by PepsiCo Global R&D.
NCT04182971 is a NA study that has completed, run by PepsiCo Global R&D. The registered enrollment target is 58 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04182971, a NA study, has completed, sponsored by PepsiCo Global R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
Compare the effects of whole orange, orange juice alone, and orange juice with added orange pomace fiber, and whole apple, apple juice alone, and apple juice with added apple pomace fiber, on 2h glycemic response.
Primary Outcome
Cmax, plasma
Interventions
- OTHER Fruit juice
- OTHER Fruit
- OTHER Fruit juice plus fiber
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2018-08-28 |
| Est. Completion | 2019-09-03 |
| Phase | NA |
What the finished NCT04182971 record still lists
NCT04182971 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Fruit juice is the first listed.
NCT04182971 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04182971 about?
NCT04182971 is a clinical study titled "Effect of Added Fruit Pomace Fiber, Juice, and Whole Fruit on Postprandial Glycemia". Compare the effects of whole orange, orange juice alone, and orange juice with added orange pomace fiber, and whole apple, apple juice alone, and apple juice with added apple pomace fiber, on 2h glycemic response.
What is the current status of trial NCT04182971?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2018-08-28. Estimated completion is 2019-09-03.
What interventions are being tested in trial NCT04182971?
The interventions under investigation include: Fruit juice (OTHER), Fruit (OTHER), Fruit juice plus fiber (OTHER).
Who is sponsoring clinical trial NCT04182971?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04182971's enrollment target sits among peer trials
58 1256th of 2000 higher than 740 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI